Research
Education
Solutions
Sign In
EN
EN - English
CN - 中文
DE - Deutsch
ES - Español
KR - 한국어
IT - Italiano
FR - Français
PT - Português
TR - Turkish
JA - Japanese
Department of Ophthalmology,
Byers Eye Institute,
Department of Ophthalmology, Byers Eye Institute
Prithvi Mruthrunjaya has not added Biography.
If you are Prithvi Mruthrunjaya and would like to personalize this page please email our Author Liaison for assistance.
Comparison of Visual Outcomes in Coats' Disease: A 20-Year Experience.
Ophthalmology Sep, 2017 | Pubmed ID: 28461016
Association between Tumor Regression Rate and Gene Expression Profile after Iodine 125 Plaque Radiotherapy for Uveal Melanoma.
Ophthalmology Oct, 2017 | Pubmed ID: 28549517
Everolimus to treat aggressive retinal astrocytic hamartoma in tuberous sclerosis complex.
Journal of AAPOS : the official publication of the American Association for Pediatric Ophthalmology and Strabismus Aug, 2017 | Pubmed ID: 28733147
Multifocal iris melanoma in a 2-year-old managed with I-125 plaque brachytherapy.
Journal of AAPOS : the official publication of the American Association for Pediatric Ophthalmology and Strabismus Oct, 2017 | Pubmed ID: 28844752
Neuro-oculo-cutaneous cavernous hemangiomas: a CCM1 mutation-associated phakomatosis.
Journal of AAPOS : the official publication of the American Association for Pediatric Ophthalmology and Strabismus Oct, 2017 | Pubmed ID: 28867399
Efficacy and Safety of Low-Dose Iodine Plaque Brachytherapy for Juxtapapillary Choroidal Melanoma.
American journal of ophthalmology Feb, 2018 | Pubmed ID: 29199010
Multi-center analysis of intraocular biopsy technique and outcomes for uveal melanoma: Ocular Oncology Study Consortium report 4.
Graefe's archive for clinical and experimental ophthalmology = Albrecht von Graefes Archiv fur klinische und experimentelle Ophthalmologie Feb, 2020 | Pubmed ID: 31807898
The Effect of Obstructive Sleep Apnea on Absolute Risk of Central Serous Chorioretinopathy.
American journal of ophthalmology Oct, 2020 | Pubmed ID: 32574769
Anti-Vascular Endothelial Growth Factor and Panretinal Photocoagulation Use after Protocol S for Proliferative Diabetic Retinopathy.
Ophthalmology. Retina Feb, 2021 | Pubmed ID: 32693033
Trends in Anti-Vascular Endothelial Growth Factor Agents and Panretinal Photocoagulation Use in Diabetic Retinopathy.
Ophthalmology. Retina Apr, 2021 | Pubmed ID: 33039592
Rates of Reoperation in 10 114 Patients with Epiretinal Membranes Treated by Vitrectomy with or without Inner Limiting Membrane Peeling.
Ophthalmology. Retina Jul, 2021 | Pubmed ID: 33127527
Discontinuation and loss to follow-up rates in clinical trials of intravitreal anti-vascular endothelial growth factor injections.
Graefe's archive for clinical and experimental ophthalmology = Albrecht von Graefes Archiv fur klinische und experimentelle Ophthalmologie Jan, 2022 | Pubmed ID: 34415363
Stanford University
Julian Wolf1,2,
Teja Chemudupati1,2,
Aarushi Kumar1,2,
Ditte K. Rasmussen1,2,
Karen M. Wai2,
Robert T. Chang2,
Artis A. Montague2,
Peter H. Tang3,4,
Alexander G. Bassuk5,6,7,
Antoine Dufour8,9,
Prithvi Mruthrunjaya2,
Vinit B. Mahajan1,2,10
1Molecular Surgery Laboratory, Stanford University,
2Department of Ophthalmology, Byers Eye Institute, Stanford University,
3Department of Ophthalmology and Visual Neurosciences, University of Minnesota,
4, Retina Consultants of Minnesota,
5Department of Pediatrics, University of Iowa,
6Department of Neurology, University of Iowa,
7The Iowa Neuroscience Institute (INI), University of Iowa,
8Department of Physiology and Pharmacology, Cumming School of Medicine, University of Calgary,
9Department of Biochemistry and Molecular Biology, Cumming School of Medicine, University of Calgary,
10, Veterans Affairs Palo Alto Health Care System
Privacy
Terms of Use
Policies
Contact Us
Recommend to library
JoVE NEWSLETTERS
JoVE Journal
Methods Collections
JoVE Encyclopedia of Experiments
Archive
JoVE Core
JoVE Business
JoVE Science Education
JoVE Lab Manual
Faculty Resource Center
Authors
Librarians
Access
ABOUT JoVE
Copyright © 2024 MyJoVE Corporation. All rights reserved